Price1.55%   +1.99
(After Hours: 130.60 +0.09 +0.07% )

Moderna INC Stock (MRNA) Latest News

Jun-02-23 05:30AM Better Healthcare AI Stock: Moderna vs. DoximityThe Motley Fool
Jun-01-23 08:00AM COVID Concerns Are Rising in China Again: Will This Send Moderna's Stock Soaring?The Motley Fool
May-31-23 05:30AM 2 Healthcare AI Stocks to Buy on the DipThe Motley Fool
May-30-23 07:00AM If You Invested $2,500 in Moderna in 2019, This Is How Much You Would Have TodayThe Motley Fool
May-07-23 03:13AM Is Moderna a Value Stock to Buy Right Now?The Motley Fool
May-06-23 05:30AM Is Moderna Building a Respiratory Vaccine Empire?The Motley Fool
May-04-23 11:21AM ‘COVID is not going away’: Moderna posts surprise quarterly profit as it looks to fall vaccinations  MarketWatch
08:49AM Here's when history says the post-Fed pause rally should start — and the two unlikely sectors to benefitMarketWatch
May-04-23 08:05AM Moderna (MRNA) Q1 Earnings and Revenues Beat EstimatesZacks Investment Research
07:29AM Here's when history says the post-Fed pause rally should start — and the two unlikely sectors to benefitMarketWatch
May-04-23 07:00AM US Stocks Set For Mixed Open As Banking Jitters Dampen Apple Earnings Buzz: Analyst Advises 'Cautious Optimism'Benzinga
05:57AM These Have Been 3 of the Best-Performing Healthcare Stocks Since 2020The Motley Fool
May-04-23 04:50AM U.S. stock futures see volatile trading on Fed and bank angst; Apple results loomMarketWatch
May-03-23 11:46AM Drug, Biotech Stocks' Q1 Earnings on May 4: REGN, ZTS & MoreZacks Investment Research
08:34AM Should You Buy Moderna (MRNA) Ahead of Earnings?Zacks Investment Research
May-02-23 02:00AM Vertex Pharmaceuticals Just Lost a Potential Rival. Is the Stock a Buy?The Motley Fool
12:06PM Vertex (VRTX) Q1 Earnings Top Estimates, Revenues Up Y/YZacks Investment Research
May-02-23 06:10AM The Zacks Analyst Blog Highlights Advanced Micro Devices, The Cigna Group, Moderna, Parker-Hannifin and RollinsZacks Investment Research
May-01-23 12:40PM Will Pfizer (PFE) Beat Expectations This Earnings Season?Zacks Investment Research
09:17AM Despite Its Falling 92%, Cathie Wood Is Buying More of This Growth StockThe Motley Fool
May-01-23 12:01PM Blockbuster IPOs Are Coming To Push The Rally HigherSeeking Alpha
Apr-28-23 08:25AM Moderna (MRNA) to Report Q1 Earnings: Will It Beat Estimates?Zacks Investment Research
05:30AM Better Healthcare AI Buy: Moderna vs. MedronicThe Motley Fool
Apr-27-23 10:02AM Moderna (MRNA) Expected to Beat Earnings Estimates: Should You Buy?Zacks Investment Research
09:00AM Moderna, Inc. (MRNA) Is a Trending Stock: Facts to Know Before Betting on ItZacks Investment Research
Apr-27-23 05:25AM 3 Stocks That Could Be Worth More Than Berkshire Hathaway by 2030The Motley Fool
Apr-26-23 03:00AM Expert Ratings for ModernaBenzinga
02:00AM Better Buy: Pfizer vs. ModernaThe Motley Fool
Apr-26-23 11:00AM Benzinga's Top Ratings Upgrades, Downgrades For April 26, 2023Benzinga
Apr-25-23 08:33AM Is Moderna Setting Expectations Too High?The Motley Fool
Apr-20-23 10:22AM What's Going On With IBM Stock Today?Benzinga
09:24AM Where Will Moderna Be in 1 Year?The Motley Fool
Apr-20-23 06:00AM Is Moderna About to Face the Same Challenge as Other Biotechs?The Motley Fool
05:30AM 3 Things About Pfizer That Smart Investors KnowThe Motley Fool
Apr-17-23 08:58AM 'Gradually, then suddenly.' Earnings expectations may be about to drop, says Morgan Stanley strategist.MarketWatch
05:30AM This Prediction May Completely Change Your Opinion of ModernaThe Motley Fool
Apr-14-23 10:57AM Drug manufacturer Catalent's stock tumbles 25% after profit warning and CFO departureMarketWatch
09:26AM 3 Medical Stocks With Solid Growth Potential to Keep Track OfZacks Investment Research
Apr-14-23 09:00AM Investors Heavily Search Moderna, Inc. (MRNA): Here is What You Need to KnowZacks Investment Research
06:20AM Is Invesco S&P 500 Equal Weight ETF (RSP) a Strong ETF Right Now?Zacks Investment Research
Apr-14-23 05:30AM Is It Too Late to Buy Pfizer Stock?The Motley Fool
Apr-13-23 11:22AM Biotech Stock Roundup: MRNA Provides Update, KALA, IFRX Surge on Regulatory NewsZacks Investment Research
08:34AM Moderna, ConocoPhillips, Vertex Pharmaceuticals And This ETF: CNBC's 'Final Trades'Benzinga
Apr-13-23 06:40AM Buffett Thinks This Is the Most Important Quality an Investor Can HaveThe Motley Fool
05:52AM Can Pfizer Beat GSK and Moderna in This $10 Billion Market?The Motley Fool
Apr-12-23 03:12AM Analyst Upgrades Arrowhead Pharma Citing 'Attractive Risk/Reward'Benzinga
11:47AM Moderna (MRNA) Posts 2027 Biz View, Down 3% on Flu Jab SetbackZacks Investment Research
Apr-12-23 09:36AM Moderna Extends YTD Drop on Mixed Early Flu Shot DataInvesting.com
09:22AM Company News for Apr 12, 2023Zacks Investment Research
Apr-12-23 07:25AM Moderna is developing a Lyme disease vaccine in a first for the company MarketWatch
Moderna, Inc. develops medicines based on messenger RNA (mRNA). Its pipeline includes development candidates for mRNA-based vaccines and therapies for use in various therapeutic areas comprising prophylactic vaccines, cancer vaccines, intratumoral immuno-oncology, localized regenerative therapeutics, systemic secreted therapeutics, and systemic intracellular therapeutics. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Cap:     |  Volume (24h):